Avoiding unanticipated adverse effects of recombinant human bone morphogenetic protein-2 therapy in craniofacial surgery with experiences from spinal applications

Journal of Craniofacial Surgery

Volumn 20, Issue 5, 2009, Pages 1626-1627

  Smoljanovic, Tomislav ^a,b   Janjanin, Sasa ^a   Bojanic, Ivan ^a  

^a KBC Zagreb   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PHOSPHATE; COLLAGEN SPONGE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

BONE GROWTH; CLINICAL PRACTICE; CRANIOFACIAL SURGERY; HUMAN; IMAGING; INTERVERTEBRAL DISK; LEG PAIN; LETTER; MORBIDITY; NONHUMAN; OSSIFICATION; OSTEOLYSIS; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SPINE SURGERY; TRABECULAR BONE; VERTEBRA BODY; VERTEBRAL CANAL;

BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; BONE RESORPTION; CRANIOFACIAL ABNORMALITIES; HUMANS; OSSIFICATION, HETEROTOPIC; OSTEOGENESIS; RECOMBINANT PROTEINS; SKULL; SPINAL CANAL; SPINE; TRANSFORMING GROWTH FACTOR BETA;

EID: 70349656955     PISSN: 10492275     EISSN: None     Source Type: Journal    
DOI: 10.1097/SCS.0b013e3181b17f81     Document Type: Letter

References (22)

1. Smith DM, Cooper GM, Mooney MP, et al. Bone morphogenetic protein 2 therapy for craniofacial surgery. J Craniofac Surg 2008;19:1244-1259
2. Wong DA, Kumar A, Jatana S, et al. Neurologic impairment from ectopic bone in the lumbar canal: a potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). Spine J 2008;8:1011-1018
3. Haid RW Jr, Branch CL Jr, Alexander JT, et al. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. Spine J 2004;4:527-538
4. Laursen M, Hoy K, Hansen ES, et al. Recombinant bone morphogenetic protein-7 as an intracorporal bone growth stimulator in unstable thoracolumbar burst fractures in humans: preliminary results. Eur Spine J 1999;8:485-490 (Pubitemid 30080570)
5. Burkus JK, Sandhu HS, Gornet MF, et al. Use of rhBMP-2 in combination with structural cortical allografts: clinical and radiographic outcomes in anterior lumbar spinal surgery. J Bone Joint Surg Am 2005;87:1205-1212
6. Hansen SM, Sasso RC. Resorptive response of rhBMP2 simulating infection in an anterior lumbar interbody fusion with a femoral ring. J Spinal Disord Tech 2006;19:130-134
7. Kuklo TR, Rosner MK, Polly DW Jr. Computerized tomography evaluation of a resorbable implant after transforaminal lumbar interbody fusion. Neurosurg Focus 2004;16:E10
8. Lewandrowski KU, Nanson C, Calderon R. Vertebral osteolysis after posterior interbody lumbar fusion with recombinant human bone morphogenetic protein 2: a report of five cases. Spine J 2007;7:609-614 (Pubitemid 47471438)
9. McClellan JW, Mulconrey DS, Forbes RJ, et al. Vertebral bone resorption after transforaminal lumbar interbody fusion with bone morphogenetic protein (rhBMP-2). J Spinal Disord Tech 2006;19:483-486
10. Meisel HJ, Schnöring M, Hohaus C, et al. Posterior lumbar interbody fusion using rhBMP-2. Eur Spine J 2008;17:1735-1744
11. Pradhan BB, Bae HW, Dawson EG, et al. Graft resorption with the use of bone morphogenetic protein: lessons from anterior lumbar interbody fusion using femoral ring allografts and recombinant human bone morphogenetic protein-2. Spine 2006;31:E277-E284
12. Vaidya R, Carp J, Sethi A, et al. Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2. Eur Spine J 2007;16:1257-1265 (Pubitemid 350104617)
13. Vaidya R, Sethi A, Bartol S, et al. Complications in the use of rhBMP-2 in PEEK cages for interbody spinal fusions. J Spinal Disord Tech 2008;21:557-562
14. Vaidya R, Weir R, Sethi A, et al. Interbody fusion with allograft and rhBMP-2 leads to consistent fusion but early subsidence. J Bone Joint Surg Br 2007;89:342-345 (Pubitemid 46563910)
15. Smoljanovic T, Pecina M. Re: Burkus JK, Transfeldt EE, Kitchel SH, et al. Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. Spine 2002;27:2396-2408.
16. Spine 2008;33:224
17. Smoljanovic T, Grgurevic L, Jelic M, et al. Regeneration of the skeleton by recombinant human bone morphogenetic proteins. Coll Antropol 2007;31:923-932
18. Seeherman H, Wozney JM. Delivery of bone morphogenetic proteins for orthopedic tissue regeneration. Cytokine Growth Factor Rev 2005;16:329-345 (Pubitemid 40910322)
19. Smoljanovic T, Bojanic I, Dapic T. Significance of early CT-evaluation after lumbar interbody fusions using recombinant human bone morphogenetic protein-2. Am J Neuroradiol 2009;30:e71
20. Smoljanovic T, Bicanic G, Bojanic I. Update of comprehensive review of the safety profile of bone morphogenetic protein in spine surgery. Neurosurgery. In press
21. Smoljanovic T, Bojanic I, Delimar D. Continuing questions regarding adverse effects of spinal interbody fusion using rhBMP-2/ACS [electronically published letter]. J Bone Joint Surg Am. Available at: http://www.ejbjs.org:80/ cgi/eletters/87/6/1205#10290. Accessed February 24, 2009
22. Howell TH, Fiorellini J, Jones A, et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int J Periodontics Restorative Dent 1997;17:124-139 (Pubitemid 127499627)